Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment

54:00
 
Share
 

Manage episode 175434913 series 1143960
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component parts into either the blood or urine, hence called non-secretory myeloma. Some non-secretory myeloma patients may produce the immunoglobulin proteins but they have defects in secretion. Due to lack of these protein biomarkers in blood and urine, it may be difficult to assess and treat the disease. Our myeloma panel is talking to Dr. Frits Van Rhee about latest developments and new options available in assessment and treatment of non-secretory myeloma. Myeloma Panel : Dr. Frits Van Rhee, Gary Petersen, Jack Aiello, Yelak Biru Internationally known multiple myeloma researcher Frits van Rhee, M.D., Ph.D is a professor of medicine in the UAMS College of Medicine and director of Developmental and Translational Medicine in the Myeloma Institute. He joined the Myeloma Institute in 2001, establishing a laboratory for developing innovative medical treatments using the bodys immune system. He is the leader of multiple National Cancer Institute-funded grant projects related to developmental therapeutics and anti-myeloma effects of so-called natural killer cells in the bodys immune system. RSVP here!

159 episodes available. A new episode about every 20 days averaging 61 mins duration .